
Global leader in genomics and sequencing technology.

Pioneer in mRNA therapeutics and vaccines.

The organism company — cell programming platform.

Spatial biology and single-cell genomics.

Next-generation immunotherapies.

AI-native drug discovery platform.

Synthetic biology and DNA synthesis.

Cloud platform for life sciences R&D.
Helixgate Biotech Review collaborates with organizations advancing the future of biotechnology, computational life sciences, and emerging innovation platforms. Through strategic partnerships, we highlight breakthrough technologies, industry developments, and the companies shaping the next generation of life science advancement.
As Helixgate continues to expand, we are actively developing partnerships with organizations driving meaningful progress in science, medicine, and advanced computational systems.
Helixgate Biotech Review regularly publishes Partnership Intelligence Briefings highlighting strategic collaborations, investment activity, and emerging initiatives across the biotechnology sector.
As Helixgate Biotech Review launches its global intelligence platform, a limited number of Founding Partners will be recognized for their early collaboration and support in advancing industry dialogue and innovation visibility.
Organizations interested in partnership opportunities with Helixgate Biotech Review may contact our editorial and strategic collaboration team. Partnership inquiries can be submitted through our contact page.
Global Biotechnology Intelligence Platform